Visit your regional NVIDIA website for local content, pricing, and where to buy partners specific to your country.
From searching a seemingly endless molecule database to generating molecules to understanding proteins, DNA and RNA, NVIDIA solutions are helping pharmaceutical and biopharmaceutical companies to discover and develop drugs faster and at a lower cost.
Drug discovery is slow and expensive despite improvements in technology, making it harder to bring drugs to market. Learn how deep learning methods and GPU-accelerated computing are starting to reverse this trend.
Read E-book: Drug Discovery With Computational Biology >
Don't miss these three upcoming Restaurant sessions at GTC.
Generative AI has the potential to accelerate many industries, including biology and healthcare. In this talk, Kimberly Powell, VP/GM of NVIDIA Healthcare and Life Sciences, will explore how the intersection of generative AI with biology and...
Engineered proteins play increasingly essential roles in industries and applications spanning pharmaceuticals, agriculture, specialty chemicals, and fuel. Machine learning could enable an unprecedented level of control in protein engineering for...
Amgen is dramatically accelerating the pace of R&D through digital innovations in our wet and dry labs. Pre-training large biomolecular language models on proprietary data is a critical part of our overall strategy. NVIDIA's AI drug discovery...
NVIDIA Clara™ drug discovery is a GPU-accelerated computational drug discovery platform that combines AI, data analytics, simulation, and visualization to support cross-disciplinary workflows in drug design and development. Clara for drug discovery helps scientists and researchers get drugs to market faster and enables new possibilities for research into disease mechanisms.
Credit: Mahendra Awale, CC BY-SA 3.0 https://creativecommons.org/licenses/by-sa/3.0, via Wikimedia Commons
Using Cara for drug discovery, researchers can apply high-performance computing applications, pretrained AI models, and domain-specific application frameworks in the areas of genomics, protein structure determination, virtual drug screening, medical imaging, NLP, and more.
NVIDIA BioNeMo Service is a cloud service for generative AI in drug discovery, offering tools to quickly customize and deploy domain-specific, state-of-the-art biomolecular models at-scale through cloud APIs.
Featured
See how NVIDIA Clara for drug discovery's MegaMolBart, a transformer-based NLP model developed with AstraZeneca and trained on millions of molecules, can quickly identify novel molecules for further investigation, increasing the probability of successful downstream experiments.
Our solutions for the healthcare industry go beyond products. Our partners are here to assist your organization at every level to build and execute transformative AI strategies, products, and services.
Stay up to date with the latest healthcare news from NVIDIA.
NVIDIA technology and our innovators across multiple disciplines can help you power transformation, innovation, and the future of your organization.
The NVIDIA Deep Learning Institute (DLI) offers hands-on training in AI, accelerated computing, and accelerated data science.
NVIDIA provides access to hundreds of GPU-accelerated containers, models, and SDKs—all the tools necessary to successfully build apps with NVIDIA technology.